Goal 2: Reduce Human Disease

mechansisms of post thrombotic syndrome

No good medical therapy exists to prevent and treat post thrombotic syndrome, the most common sequlae from a deep vein thrombosis. Recent trial data suggests that compression stockings do not prevent PTS, and thrombolysis is expensive and risky. The basic mechanisms related to fibrosis of the vein wall are not well understood.

Submitted by (@henke0)

Voting

1 net vote
5 up votes
4 down votes
Active

Goal 2: Reduce Human Disease

Understand the Impact of Thrombosis in Children with Cancer

CC: Despite the potential impact that venous thrombotic events (VTE) have on children with cancer, several unresolved issues remain. To date, we are yet to understand: - incidence/prevalence of VTE according to cancer type/staging - ideal imaging modalities to diagnose/follow VTE - thromboprophylaxis according to thrombosis risk stratification (development of VTE predictors) - efficacy/safety to anticoagulate children ...more »

Submitted by (@leonardo.brandao)

Voting

30 net votes
38 up votes
8 down votes
Active

Goal 4: Develop Workforce and Resources

Economic and Sustainable Infrastructure for Basic Scientists and Physician Researchers in Healthcare Networks

This will require a new process of partnerships between successful basic scientists and the physician who is committed to a synergistic relationship with the investigators in order to unravel the pathophysiology of disease. The failure of the part-time “MD trainee scientist” due to increasing clinical requirements to complete their fellowship, has only reinforced the impression that physicians no longer belong in the ...more »

Submitted by (@dianenugent7)

Voting

20 net votes
24 up votes
4 down votes
Active

Goal 2: Reduce Human Disease

Mechanisms of Uterine Hemostasis

What are the mechanisms of uterine hemostasis? Endogenous mechanisms of uterine hemostasis protect women from the bleeding challenges of miscarriage, childbirth, and menstruation. Dysregulation of these mechanisms has implications for the critical public health problems of hormonally-induced venous thromboembolism and hormonally-induced arterial thromboembolism (myocardial infarction and stroke). Our current understanding ...more »

Submitted by (@andra.james)

Voting

14 net votes
19 up votes
5 down votes
Active

Goal 2: Reduce Human Disease

Funding for Hemostasis & Thrombosis Research

Thrombotic disorders, a result of the inappropriate activation of the hemostatic system, remain major causes of morbidity and mortality in the United States. Cancer, cardiovascular disease, trauma, and many of the other causes of death in the U.S. frequently culminate in a fatal thrombotic event. Notably, thromboembolic disease affects 500,000 people annually and leads to 100,000 deaths in the United States alone. Current ...more »

Submitted by (@abrams)

Voting

128 net votes
136 up votes
8 down votes
Active

Goal 3: Advance Translational Research

Engineering Challenges for Next Generation VADs

Critical challenges to overcome include the development of non-platelet activating impellers and hypothrombogenic surfaces in modern ventricular assist devices (VADs). Percutaneous and transcutaneous electric drive systems will need to evolve, and clinical research is needed to reduce thromboembolism and bleeding (acquired von Willebrand syndrome). Adverse events may also be further reduced if smaller pumps, for partial ...more »

Submitted by (@nhlbiforumadministrator1)

Voting

6 net votes
27 up votes
21 down votes
Active